adnexa

(redirected from adnexus)
Also found in: Dictionary, Thesaurus, Medical.

adnexa

[ad′neks·ə]
(biology)
Subordinate or accessory parts, such as eyelids, Fallopian tubes, and extraembryonic membranes.
References in periodicals archive ?
Bringing Adnexus into the Bristol-Myers Squibb family builds upon a successful and productive collaboration between the two companies in oncology and is an important step in accelerating the strategic transformation of our pharmaceutical business to a biopharma business model," said Jim Cornelius, chief executive officer, Bristol-Myers Squibb.
He previously served as CEO of Adnexus Therapeutics, a Flagship VentureLabs-founded pioneer of a new class of protein therapeutics, which was acquired by Bristol-Myers Squibb Company for $505 million.
Notable exits have included Adnexus Therapeutics, Morphotek, Hypnion, CGI, Aveo, BG Medicine, and Accuri.
Companies Listed Abbott Laboratories Accelrys Adnexus Therapeutics Advanced Innovative Medicine AIS AKH Biobank AllCells Allied Minds AlloSource American CryoStem American Type Culture Collection Amgen Analytical Biological Services ARUP Laboratories ASPREE Healthy Aging Biobank AssureImmune Asterand AstraZeneca Aurora Biomed Australasian Biospecimen Network
Past Polaris-backed successes include: Adnexus (acquired by BMS), Advanced Inhalation Research (acquired by Alkermes), Akamai Technologies (AKAM), Allaire (ALLR, acquired by Adobe), Alnylam Pharmaceuticals (ALNY), Asthmatx (acquired by Boston Scientific), Glycofi (acquired by Merck), Ironwood (IRWD), LogMeIn (LOGM), Momenta Pharmaceuticals (MNTA), Powersoft (PWRS, acquired by Sybase), Solidworks, and TechTarget (TTGT).
Carter held management positions in finance with Adnexus Therapeutics and Transkaryotic Therapies/Shire Pharmaceutical Group, Plc.
With a primary focus on technology, healthcare, and energy, portfolio companies have included Adify, Adnexus Therapeutics, Apple Computer, Centocor, Check Point Software, DoubleClick, Gilead Sciences, Idec Pharmaceuticals, Illumina, Intel, Millennium Pharmaceuticals, Sirna Therapeutics, StrataCom, and Vontu.